Metformin for the treatment of polycystic ovary syndrome

被引:58
作者
Barbieri, RL [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA
关键词
D O I
10.1016/S0029-7844(03)00045-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To familiarize obstetrician-gynecologists with the use of metformin for the treatment of polycystic ovary syndrome (PCOS). DATA SOURCES: Using OVID, 94 English-language articles published after 1966 indexed with the key words "metformin" and "polycystic ovary syndrome" were identified. METHODS OF STUDY SELECTION: Studies were excluded if they did not have a control group, did not use the National Institutes of Health definition of PCOS, did not have a clinical outcome as an end point, and were not in the English language. Reviews were also excluded, leaving 21 articles for inclusion. TABULATION, INTEGRATION, AND RESULTS: Three clinical trials reported that for the treatment of anovulatory infertility caused by PCOS, metformin plus clomiphene is more effective than domiphene alone in inducing ovulation. For the treatment of irregular menses caused by PCOS in women not attempting conception, metformin therapy may restore ovulatory menses in the majority of women. However, most women will require 4-6 months of metformin therapy before they achieve ovulatory menses. In obese women, metformin plus a low-calorie diet may be associated with more weight loss than a low-calorie diet alone. CONCLUSION: Polycystic ovary syndrome is a common gynecologic endocrine disorder. Obstetrician-gynecologists should be familiar with the indications and contraindications for the use of metformin in their practice.
引用
收藏
页码:785 / 793
页数:9
相关论文
共 72 条
[31]   Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: Role of insulin sensitivity and luteinizing hormone [J].
Huber-Buchholz, MM ;
Carey, DGP ;
Norman, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1470-1474
[32]   Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism [J].
Ibáñez, L ;
Valls, C ;
Ferrer, A ;
Marcos, MV ;
Rodriguez-Hierro, F ;
De Zegher, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3595-3598
[33]   Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche [J].
Ibáñez, L ;
Valls, C ;
Potau, N ;
Marcos, MV ;
de Zegher, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3526-3530
[34]   Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine [J].
Ikeda, T ;
Iwata, K ;
Murakami, H .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (07) :887-890
[35]   Effects of metformin on early pregnancy loss in the polycystic ovary syndrome [J].
Jakubowicz, DJ ;
Iuorno, MJ ;
Jakubowicz, S ;
Roberts, KA ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :524-529
[36]  
Kahn R, 1998, DIABETES CARE, V21, P310
[37]   Beneficial effects of metformin in normoglycemic morbidly obese adolescents [J].
Kay, JP ;
Alemzadeh, R ;
Langley, G ;
D'Angelo, L ;
Smith, P ;
Holshouser, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (12) :1457-1461
[38]   IMPROVEMENT IN ENDOCRINE AND OVARIAN-FUNCTION DURING DIETARY-TREATMENT OF OBESE WOMEN WITH POLYCYSTIC-OVARY-SYNDROME [J].
KIDDY, DS ;
HAMILTONFAIRLEY, D ;
BUSH, A ;
SHORT, F ;
ANYAOKU, V ;
REED, MJ ;
FRANKS, S .
CLINICAL ENDOCRINOLOGY, 1992, 36 (01) :105-111
[39]   Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study [J].
Knochenhauer, ES ;
Key, TJ ;
Kahsar-Miller, M ;
Waggoner, W ;
Boots, LR ;
Azziz, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) :3078-3082
[40]  
Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512